Antifungal Susceptibility Testing Practices at Acute Care Hospitals Enrolled in the National Healthcare Safety Network, United States, 2011-2015

Snigdha Vallabhaneni; Mathew Sapiano; Lindsey M Weiner; Shawn R Lockhart; Shelley Magill

doi:10.1093/ofid/ofx175

Antifungal Susceptibility Testing Practices at Acute Care Hospitals Enrolled in the National Healthcare Safety Network, United States, 2011-2015

Open Forum Infect Dis. 2017 Aug 16;4(4):ofx175. doi: 10.1093/ofid/ofx175. eCollection 2017 Fall.

Authors

Snigdha Vallabhaneni¹, Mathew Sapiano², Lindsey M Weiner², Shawn R Lockhart¹, Shelley Magill²

Affiliations

¹ Mycotic Diseases Branch and.
² Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

Abstract

We assessed availability of antifungal susceptibility testing (AFST) at nearly 4000 acute care hospitals enrolled in the National Healthcare Safety Network. In 2015, 95% offered any AFST, 28% offered AFST at their own laboratory or at an affiliated medical center, and 33% offered reflexive AFST. Availability of AFST improved from 2011 to 2015, but substantial gaps exist in the availability of AFST.

Keywords: antifungal agents; antifungal susceptibility testing; candidemia; laboratory practices; resistance.